All In MedTech

FDA Clearance Tracker · P030019-S014

ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 30, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 30, 2011

Approved

Time to decision

927 days

Received Jun 16, 2009. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030019-S014
Device name
ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONAN
Applicant location
Beford, MA
Received
Jun 16, 2009
Decided
Dec 30, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P030019

Device type

Device class
Class III

Every decision under product code MOZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE IN BEDFORD, MASSACHUSETTS.

Source documents

Other decisions for Anika Therapeutics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.